We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
We are experienced in Phase I – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.
Industry leader with over 16 years of experience designing and delivering value-driven Expanded Access (EAPs) and Post-Trial Access Programs.
